ArticleClinical, cosmetic and investigational dermatology2024
Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up.
Biao Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.